CN1068785C - Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer - Google Patents
Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer Download PDFInfo
- Publication number
- CN1068785C CN1068785C CN98110254A CN98110254A CN1068785C CN 1068785 C CN1068785 C CN 1068785C CN 98110254 A CN98110254 A CN 98110254A CN 98110254 A CN98110254 A CN 98110254A CN 1068785 C CN1068785 C CN 1068785C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- medicine
- patent medicine
- portions
- burn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 17
- 201000010099 disease Diseases 0.000 title claims description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 20
- 208000025865 Ulcer Diseases 0.000 title description 9
- 231100000397 ulcer Toxicity 0.000 title description 9
- 230000002500 effect on skin Effects 0.000 title 1
- 206010040943 Skin Ulcer Diseases 0.000 claims abstract description 13
- 231100000019 skin ulcer Toxicity 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 11
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241001313855 Bletilla Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 241000700199 Cavia porcellus Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 4
- 206010018693 Granuloma inguinale Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 210000000589 cicatrix Anatomy 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010033078 Otitis media Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000035985 Body Odor Diseases 0.000 description 2
- 206010055000 Bromhidrosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010016936 Folliculitis Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 208000023637 Multiple injury Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229940125718 cold curing agent Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses external applied Chinese patent medicine used for treating scalds, burns, skin ulcers, etc., which belongs to the field of medicinal technology. The present invention has a technical scheme that the Chinese patent medicine comprises the components of the proportion by weight: 60 to 110 portions of dried alum, 30 to 80 portions of rhubarb, 30 to 80 portions of calcined gypsum, 20 to 30 portions of bletilla tubers, 1 to 5 portions of frankincense and 2 to 8 portions of myrrh which are prepared into powder according to the conventional preparation process of traditional Chinese medicine as externally applied medicine. The present invention has a scientific recipe and has no toxic or side effect. Medicinal plants used by the medicine come from the fifth edition of China 'pharmacopoeia'. An effective rate achieves 100% by a clinical test.
Description
The present invention relates to Chinese patent drug technique field, relate in particular to a kind of external Chinese patent medicine that is used for the treatment of diseases such as scald, burn, skin ulcer.
At present use medicine for external use such as JINGWANHONG, moist expose burn ointment usually, treat as oral medicine etc. with transfusion, anti-sanguinin etc. at the medicine that is used for the treatment of scalds, the disease of burning; The treatment medicine that is used for eczema mainly contains antibiotic, Le-Fu-Ye bacteriostatic etc.; Injure wound outward, the ulcer medication mainly is adhesive bandage, yellow amine crystallization, antibiotic etc.; Medication to otitis media, folliculitis, impetigo mainly is an antibiotic, and the medicine for treatment that beriberi is festered has yellow amine crystallization, JIAOXIAN YICIJING etc.; The treatment medicine of pudendal ulcer mainly contains antibiotic, hismanal, ciprofloxacin etc., and the medicine of above various diseases is from the statistical result analysis, and the one drug effect is not remarkable, and treatment time is long; Its two side effect is big, and healing time is long, and patient's tolerance is relatively poor, thereby excavates Chinese medical material repository, seeks that a kind of can to utilize the external Chinese patent medicine of the multiple injury of Chinese herbal treatment be a positive problem.
The objective of the invention is to improve the deficiency of prior art, and a kind of low price is provided, easy to use, the external Chinese patent medicine that is used for the treatment of multiple diseases such as scald, burn, skin ulcer that therapeutic effect is good.
The objective of the invention is to be achieved by following technical solution: a kind of external Chinese patent medicine that is used for the treatment of diseases such as scald, burn, skin ulcer, it is characterized in that its weight consists of dried Alumen 60-110 part, Radix Et Rhizoma Rhei 30-80 part, Gypsum Fibrosum Preparatum 30-80 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Olibanum 1-5 part, Myrrha 2-8 part.
External Chinese patent medicine of the present invention embodiment preferably is: a kind of external Chinese patent medicine that is used for the treatment of diseases such as scald, burn, skin ulcer, it is characterized in that its weight consists of dried Alumen 75-95 part, Radix Et Rhizoma Rhei 45-65 part, Gypsum Fibrosum Preparatum 45-65 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 23-27 part, Olibanum 2-4 part, Myrrha 4-6 part.
The embodiment of external Chinese patent medicine the best of the present invention is that a kind of Chinese patent medicine that is used for the treatment of diseases such as scald, burn, skin ulcer is characterized in that its weight consists of 80 parts of dried Alumens, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Gypsum Fibrosum Preparatum, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3 parts of Olibanums, 5 parts of Myrrhas.
External Chinese patent medicine of the present invention is to make powder according to the conventional technology of preparing of Chinese medicine.
The principles of formulating prescriptions of external Chinese patent medicine of the present invention are, reducing swelling and alleviating pain, and sterilizing and itch-relieving, removing the necrotic tissue and promoting granulation, blood circulation promoting and blood stasis dispelling pulls out dried removing dampness, arresting hemostasia and suppuration, the no cicatrix in back more, the effect of Chinese medicinal ingredients of the present invention is:
Dried Alumen puckery cold in nature for the white opacity crystalline solid, has detoxifcation, doctor's skin ulcer, and removing dampness is antipruritic, holds back to rush down hemostasis, the switching of eliminating the phlegm, the effect of heat clearing away jaundice eliminating is mainly used in the treatment scabies, diseases such as eczema.
Radix Et Rhizoma Rhei bitter in the mouth cold in nature has stasis removing, and the effect that eliminating fire and detoxication, clots absorbing stimulate the menstrual flow cures mainly the excess-heat constipation, the stomachache distension, and dysentery, jaundice, the blood stasis amenorrhea, the conjunctival congestion aphtha, diseases such as carbuncle, external application can be controlled scald.
Gypsum Fibrosum Preparatum acrid-sweet flavor in Great Cold cures mainly the hyperpyrexia excessive thirst, and lung-heat is breathed with cough and disease such as toothache due to stomach-fire, but the promoting tissue regeneration and ulcer healing that is for external application.
Pseudobulbus Bletillae (Rhizoma Bletillae) cold nature bitter in the mouth has tonifying the lung, and the hemostatic effect cures mainly the deficiency of the lung and owes to cough, and spits blood diseases such as ulcer haemorrhage.
The little bitter in the mouth suffering of Olibanum cures mainly breast abdomen pain, dysmenorrhea, traumatic injury, diseases such as carbuncle.
Do not have the flat bitter in the mouth of the property of medicine, have promoting blood circulation to remove blood stasis, effects such as reducing swelling and alleviating pain cure mainly carbuncle and swell and ache, diseases such as traumatic injury.
Medicament composing prescription science of the present invention, all composition comes from the 5th edition Chinese medicine that records of China's " pharmacopeia ", does not have toxic and side effects, its described various kinds of drug has been brought into play reducing swelling and alleviating pain, sterilizing and itch-relieving, removing the necrotic tissue and promoting granulation, blood circulation promoting and blood stasis dispelling pulls out in removing dampness arresting hemostasia and suppuration, more the effect of no cicatrix after, to burn, scald otitis media, eczema ulcer, beriberi is festered, various carbuncle sore, folliculitis, cloudy place bromhidrosis, impetigo, oral ulcer, pudendal ulcer, trauma ulcer, diseases such as skin grafting dermepenthesis operation all have the positive therapeutic effect.
The test example
1, the skin acute toxicity test of external Chinese patent medicine of the present invention
(1) test objective: observe the toxic reaction that animal subject produces because of Absorption intact skin and damaged skin short term contact.
(2) animal is selected: 8 of the white rabbit (divide two dosage groups, 4 every group, male and female half and half) of selecting 2-2.5kg.
(3) test is prepared: white rabbit is exposed the exocuticle of white rabbit being tried preceding 24 hours with its both sides, back shearing machine unhairing, and the unhairing scope is each 7.5cm * 10cm of both sides, adds up to 150cm
2, the skin at unhairing position must not be injured because of unhairing, otherwise should not make the toxicity test of complete skin.
(4) test method: with (4 every group of two dosage groups of 8 branches of the rabbit after the unhairing, each two of male and female), carried out disinfection to trying skin (every is tried the contrast test that rabbit carries out intact skin and damaged skin simultaneously) respectively, (small dose group is drawn 2 groined types to scratch epidermis with the sterile surgical cutter as groined type, heavy dose of group is drawn 8 groined types), slight oozing of blood degree of being appears with skin.Directly spread to apply with Chinese medicine powder of the present invention and scratch the place, with gauze and immobilization with adhesive tape, with the rabbit sub-cage rearing after the wrapping at epidermis.
(5) observe and the result: give to be subjected to behind the reagent thing 24 hours, find no and be poisoned to death, binder is removed, and with warm water remove remain on the skin be subjected to the reagent thing time find that all the oozing of blood positions continue to observe seven days all in knot, 8 of two dosage groups are tried none death of rabbit, and big of dry and hard epidermis all comes off, and the epidermis after coming off does not have cicatrix, in the observation period, tried the outward appearance of rabbit, the mental status, appetite, stool, the colour of skin is breathed no any unusual.
Above-mentioned evidence: external Chinese patent medicine of the present invention is nontoxic, safety, and hemostasis and pain-relieving pulls out dried removing dampness at short notice, more the therapeutic effect of the no cicatrix in back.
2, the skin anaphylactic test of external Chinese patent medicine of the present invention
(1) test objective: the purpose of this test is to observe animal skin, and after repeating contact and being subjected to the reagent thing, medicine is at the intravital sensitivity response of flesh.
(2) animal is selected: the albino guinea-pig (respectively 15 of male and female) that to select 30 body weight be 250-300g.
(3) test is prepared: being tried preceding 24 hours, 3 * 3cm is respectively removed in the guinea pig back both sides
2Hair, expose white exocuticle, the skin at unhairing position must not be injured because of unhairing, otherwise be not useable for the test.
(4) test method
1. test grouping, by body weight, sex is divided into three groups at random with Cavia porcellus, and 10 every group, male and female half and half.First group is tried medicine of the present invention; Second group of negative control gives excipient (lanoline); The 3rd group of positive control, give 1% 2,4-dinitro-chloro-benzene (DNCB).
2. sensitization contact: get and be subjected to reagent thing 0.2g, be mixed with an amount of lanoline excipient, be coated in and tried depilation district, back, Cavia porcellus left side, fix every animal sub-cage rearing, lasting 6 hours with gauze and adhesive plaster.The 7th day and the 14th day, in kind to repeat once, the negative control group Cavia porcellus is coated with lanoline; Positive thing matched group is coated with 1%DNCB, and method is with being subjected to reagent thing group.
3. excite contact: in last give be subjected to reagent thing sensitization after 14 days, will be subjected to reagent thing 0.2g to be applied to depilation district, guinea pig back right side, remove after 6 hours and be subjected to the reagent thing, observe the skin allergy situation at once, then in 24,48, observed once more in 72 hours.Negative and positive controls operation and observational technique is same is subjected to reagent thing group is the lanoline excipient but negative control group is coated with, and positive controls is coated with is 1% DNCB.
(5) observe and the result: through to 6 hours the observation of sensitization that is subjected to reagent thing group Cavia porcellus and the 7th day, repeated sensitization test (STT) on the 14th day to observe, sensitization contact negative and positive controls is observed and is all found no the erythema generation; After this to exciting the observation of contact test, also find no the generation of erythema phenomenon.By above evidence, external used medicine of the present invention is more normal to dermoreaction, no sensitization reaction.
3, the clinical trial of external Chinese patent medicine of the present invention:
External Chinese patent medicine of the present invention has carried out clinical practice half a year in three hospitals above county level, treats 564 exceptions altogether and hinders disease patient, wherein wound 128 examples, 58 examples of burning, scald 65 examples, eczema ulcer 86 examples, oral ulcer 46 examples, beriberi ulcer 64 examples, otitis media 38 examples, pudendal ulcer 89 examples, cure rate reaches 95%, the treatment effective percentage reaches 100%, and its typical case history is now taken passages as follows:
1, Lee * *, the man, 70 years old, suffer from pudendal ulcer for many years, once went to a doctor in the related hospitals treatment, recovery from illness is always applied the i.e. recovery from illness after twice 7 days of this medicine through spreading.
2, Liu * *, the woman 11 years old, because of suffering from trauma ulcer, spreads and applies this medicine and fully recover after one time 2 days.
3, Sui * *, the man 35 years old, because of flame burn, spreads and applies this medicine secondary, i.e. recovery from illness after seven days.
4, Zhu * *, the woman, 10 years old, suffer from carbuncle skin ulcer diameter 5cm, pain unbearably, this medicine of application after half an hour pain disappear, apply a deuterzooid medicine after three days in addition, i.e. recovery from illness after seven days.
5, Zhu * *, the man, 25 years old, suffered from cloudy place bromhidrosis several years, through this medicated powder of external application secondary, recovery from illness after 3 days.
6, Song * *, the woman, 62 years old, because of the scald left arm of opening fire, the part is ulcer, this medicine of external application 2 times promptly reached recovery from illness in 10 days,
The specific embodiment of medicine of the present invention is as follows:
Embodiment 1
Take by weighing dried Alumen 60g, Radix Et Rhizoma Rhei 30g, Gypsum Fibrosum Preparatum 30g, Pseudobulbus Bletillae (Rhizoma Bletillae) 20g, Olibanum 1g, Myrrha 2g, with above-mentioned Chinese crude drug routinely the Chinese medicine preparation technology make powder and be described external Chinese patent medicine of the present invention.
Embodiment 2
Take by weighing dried Alumen 110g, Radix Et Rhizoma Rhei 80g, Gypsum Fibrosum Preparatum 80g, Pseudobulbus Bletillae (Rhizoma Bletillae) 30g, Olibanum 5g, Myrrha 8g, with above-mentioned Chinese crude drug routinely the Chinese medicine preparation technology make powder, be described external Chinese patent medicine of the present invention.
Embodiment 3
Take by weighing dried Alumen 75g, Radix Et Rhizoma Rhei 45g, Gypsum Fibrosum Preparatum 45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 23g, Olibanum 2g, Myrrha 4g, with above-mentioned Chinese crude drug routinely the Chinese medicine preparation technology make powder, can obtain external Chinese patent medicine of the present invention.
Embodiment 5
Take by weighing dried Alumen 80g, Radix Et Rhizoma Rhei 50g, Gypsum Fibrosum Preparatum 50g, Pseudobulbus Bletillae (Rhizoma Bletillae) 25g, Olibanum 3g, Myrrha 5g, with above-mentioned Chinese crude drug routinely the Chinese medicine preparation technology make powder, can obtain external Chinese patent medicine of the present invention.
Claims (4)
1, a kind of external Chinese patent medicine that is used for the treatment of diseases such as scald, burn, skin ulcer is characterized in that its weight consists of dried Alumen 60-110 part, Radix Et Rhizoma Rhei 30-80 part, Gypsum Fibrosum Preparatum 30-80 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Olibanum 1-5 part, Myrrha 2-8 part.
2, the external Chinese patent medicine of diseases such as treatment scald according to claim 1, burn, skin ulcer is characterized in that its weight consists of dried Alumen 75-95 part, Radix Et Rhizoma Rhei 45-65 part, Gypsum Fibrosum Preparatum 45-65 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 23-27 part, Olibanum 2-4 part, Myrrha 4-6 part.
3, the external Chinese patent medicine of diseases such as treatment scald according to claim 1, burn, skin ulcer is characterized in that its weight consists of 80 parts of dried Alumens, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Gypsum Fibrosum Preparatum, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3 parts of Olibanums, 5 parts of Myrrhas.
4, according to the external Chinese patent medicine of diseases such as the described treatment scald of arbitrary claim in the claim 1 to 3, burn, skin ulcer, it is characterized in that described external Chinese patent medicine is a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110254A CN1068785C (en) | 1998-05-29 | 1998-05-29 | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110254A CN1068785C (en) | 1998-05-29 | 1998-05-29 | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1237426A CN1237426A (en) | 1999-12-08 |
| CN1068785C true CN1068785C (en) | 2001-07-25 |
Family
ID=5220319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98110254A Expired - Fee Related CN1068785C (en) | 1998-05-29 | 1998-05-29 | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1068785C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101041014B (en) * | 2007-04-21 | 2010-07-28 | 孟祥宝 | Plaster for treating scald and burn for external application |
| CN103191205B (en) * | 2013-04-22 | 2014-06-25 | 吉林农业大学 | Externally-used medicine for treating grease-heel of equus animals and preparation method thereof |
| CN107995867A (en) * | 2017-10-27 | 2018-05-04 | 江苏奇力康皮肤药业有限公司 | A long-acting slow-release traditional Chinese medicine cold compress for treating skin ulcers |
| CN109908270A (en) * | 2019-04-30 | 2019-06-21 | 张华利 | A kind of medicament for treating scald |
| CN110876779B (en) * | 2019-12-23 | 2021-11-09 | 山东中医药大学 | Traditional Chinese medicine composition for treating oral ulcer and preparation method and application thereof |
-
1998
- 1998-05-29 CN CN98110254A patent/CN1068785C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中原医刊1986,(4) 1986.1.1 曾冲 烧烫糊剂治疗烧烫伤 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1237426A (en) | 1999-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101310748A (en) | Ointment for treating empyrosis | |
| CN101049466A (en) | Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method | |
| CN1548139A (en) | Bedsore ointment and its prepn process | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| CN112618646A (en) | Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof | |
| JP3126583B2 (en) | Burn treatment agent, method for producing the same, and treatment method using the same | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN108686103B (en) | Hemostatic traditional Chinese medicine composition and multifunctional emergency hemostatic composite material | |
| CN1085797A (en) | Eliminating inflammation and expelling toxin sore treatment ointment and preparation method thereof | |
| CN102824449B (en) | A kind of external-use tincture for the treatment of decubital ulcer, traumatic infection, diabetic dermopathy | |
| CN1268357C (en) | Medicine composition for treating furuncle, abscess, carbuncle, furuncle, burn and scald | |
| CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
| CN1183950C (en) | Chinese herbal medicine preparation for treating burns | |
| CN103263451B (en) | Traditional Chinese medicine for mainly treating trauma as well as sore and ulcer, preparation method and application of traditional Chinese medicine | |
| CN100471518C (en) | Wuhu Baibingsan | |
| CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
| CN103432259B (en) | Traditional Chinese medicine preparation as well as preparation method and use | |
| CN100402074C (en) | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof | |
| CN108392572B (en) | Plaster for removing stasis, promoting tissue regeneration, healing sore and relieving pain and preparation method and application thereof | |
| CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| CN1965884A (en) | Chinese medicine for treating traumatic bleeding and swelling pain cause by skin sore and carbuncle | |
| CN103394009B (en) | Traditional Chinese medicine for treating trauma and diabetes foot ulcer and preparation method | |
| CN110624032A (en) | Ointment for treating burns and scalds and preparation method thereof | |
| CN100368003C (en) | Medicine for treating carbuncle and furuncle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |